•  

Posts Tagged: blood brain barrier

Ontario advancing nine medical research projects in cancer, heart disease and sleep apnea to market

Applications for next MSc PoP granting round being accepted until February 25, 2016 TORONTO (January 26, 2016) — Nine Ontario-based medical research projects built on great science with potential for significant economic impact are advancing a step closer to market entry thanks to funding from Ontario Centres of Excellence’s Medical Sciences Proof-of-Principle (MSc PoP) program. The projects range from cancer to heart disease to sleep apnea in children. Applications for the next MSc PoP granting round are open until March 4, 2016. To ...
February 4, 2016 in BresoTec Inc., Funding or Fundraising-Announcements, Government Partners, Licenseable Technologies, Member Institutions, News, Partnerships, Portfolio, St. Michael's Hospital, Start-Up Companies, Sunnybrook Health Sciences Centre, The Hospital for Sick Children (SickKids), University Health Network, University of Toronto
Read more

Triphase announces Health Canada approval to initiate Marizomib Phase 1 study in recurrent glioma patients

TORONTO and SAN DIEGO (September 25, 2015) — Triphase Accelerator Corporation, a private drug development company dedicated to advancing novel compounds through Phase 2 proof-of-concept, today announced that it has received approval from Health Canada to initiate its Phase 1 clinical study of marizomib in combination with bevacizumab (Avastin®) in patients with recurrent malignant glioma in Canada. Marizomib is a novel and highly potent proteasome inhibitor that readily penetrates the blood brain barrier. It prevents the breakdown of proteins involved in signal ...
September 25, 2015 in MaRS Discovery District, Member Institutions, News, Portfolio, Start-Up Companies, The Ontario Institute for Cancer Research (OICR), Triphase Accelerator Corporation
Read more